Scarica l'app Stockscreener
30.00
8.95%
-2.95
Dopo l'orario di chiusura:
30.01
0.01
+0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$32.95
Aprire:
$32.57
Volume 24 ore:
282.89K
Relative Volume:
1.31
Capitalizzazione di mercato:
$610.82M
Reddito:
$71.10M
Utile/perdita netta:
$-6.38M
Rapporto P/E:
-24.98
EPS:
-1.2009
Flusso di cassa netto:
$-39.84M
1 W Prestazione:
+12.19%
1M Prestazione:
+11.90%
6M Prestazione:
+7.84%
1 anno Prestazione:
+17.92%
Intervallo 1D:
$29.83
$33.33
Intervallo di 1 settimana:
$26.23
$33.33
Portata 52W:
$20.23
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Nome
Assembly Biosciences Inc
Settore
Industria
Telefono
(833) 409-4583
Indirizzo
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
30.00 | 670.88M | 71.10M | -6.38M | -39.84M | -1.2009 |
VRTX
Vertex Pharmaceuticals Inc
|
515.57 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.86 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
986.80 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
211.94 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.66 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Guggenheim | Buy |
| 2024-09-20 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-09-13 | Iniziato | H.C. Wainwright | Neutral |
| 2021-09-02 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Downgrade | Jefferies | Buy → Hold |
| 2020-10-19 | Iniziato | Truist | Buy |
| 2019-10-16 | Iniziato | Mizuho | Buy |
| 2018-11-19 | Iniziato | Leerink Partners | Outperform |
| 2018-10-08 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Iniziato | Robert W. Baird | Outperform |
| 2018-04-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Iniziato | Jefferies | Buy |
| 2017-05-30 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
Assembly Biosciences reports Q2 EPS (20c), consensus (52c) - TipRanks
Assembly Biosciences: Gilead Advancements For GS-1179 And ABI-6250 Is A Bullish Signal - Seeking Alpha
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Assembly Biosciences (ASMB) sees Paradigm BioCapital report 7.8% ownership stake - Stock Titan
Why (ASMB) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Trading Up 8.2% on Strong Earnings - marketbeat.com
Assembly Biosciences (ASMB) Stock Jumps As Losses Shrink And Revenue Builds - Sahm
Assembly Biosciences earnings beat by $0.53, revenue topped estimates - Investing.com Canada
Assembly Biosciences (ASMB) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Assembly Biosciences (NASDAQ:ASMB) Issues Quarterly Earnings Results, Beats Expectations By $0.52 EPS - marketbeat.com
Assembly Biosciences (ASMB) boosts cash to $320M and narrows loss - Stock Titan
Assembly Biosciences: Q2 Earnings Snapshot - AOL.com
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates - manilatimes.net
Assembly Biosciences Projects Operations Funded Into 2029 With $75M Gilead Payment Due - Stock Titan
Assembly Biosciences (ASMB): Janus Henderson Group discloses 1,359,514-share, 6.9% beneficial stake - Stock Titan
Farallon Capital Management Expands Stake in Assembly Biosciences Inc (ASMB) with Strategic Add - GuruFocus
ASMB Q2'26 Earnings: revenue estimate is 8.60M USD - TradingView
Understanding Momentum Shifts in (ASMB) - Stock Traders Daily
Assembly Biosciences Inc (ASMB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Assembly Biosciences (ASMB) Expected to Post Earnings on Wednesday - marketbeat.com
Eversept Partners LP Decreases Holdings in Assembly Biosciences, Inc. $ASMB - marketbeat.com
ASMB|Assembly Biosciences Inc|Price:25.870|Chg%:+0.320 - TradingKey
Assembly Biosciences Inc (ASMB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Assembly Biosciences Inc (ASMB) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
TradingKey - TradingKey
Assembly Biosciences Market Sentiment - Benzinga España
Assembly Biosciences Inc (ASMB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - tradingkey.com
Assembly Biosciences Inc (ASMB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Avoiding Lag: Real-Time Signals in (ASMB) Movement - Stock Traders Daily
Assembly Biosciences (ASMB) Surges 5.6%: Biotech Stock Breaks Above Key Moving AverageLow Beta Factor - dars.gov.et
Assembly Biosciences Closes Securities Offering - Moomoo
Assembly Biosciences strengthens antiviral plat... - Pluang
Assembly Biosciences: A Gilead-Backed Antiviral Option With More Embedded Leverage Than The Market Appreciates - Seeking Alpha
Assembli to Produce Big Ten Conference Activation at Fanatics Fest in New York - GlobeNewswire Inc.
Enterprise value to EBIT forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Enterprise value to EBIT forward of Assembly Biosciences, Inc. – HAM:V7B - TradingView
Enterprise value to EBIT forward of Assembly Biosciences, Inc. – FWB:V7B - TradingView
Price to earnings forward of Assembly Biosciences, Inc. – FWB:V7B - TradingView
Enterprise value to revenue forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Assembly Biosciences (ASMB) Holds Steady Near Resistance ZoneOverbought Signal Alerts - dars.gov.et
Enterprise value to EBITDA forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Assembly Biosciences Inc: Plans to Initiate a - Moomoo
ASMBAssembly Biosciences Inc Options - Finviz
Discipline and Rules-Based Execution in ASMB Response - Stock Traders Daily
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Value Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS:ASMB) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000 Value Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000 Index - marketscreener.com
Health Care had the best week vs. the S&P 500 on record (XLV:NYSEARCA) - Seeking Alpha
Assembly Biosciences Inc Azioni (ASMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Assembly Biosciences Inc Azioni (ASMB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bjorkquist Jeanette M | PFO and PAO |
Mar 30 '26 |
Sale |
26.69 |
328 |
8,755 |
11,089 |
| White Nicole S | Chief Manufacturing Officer |
Mar 30 '26 |
Sale |
26.69 |
197 |
5,258 |
37,477 |
2.20%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):